Melanoma Home
Melanoma Mission
Melanoma Consulting Panel
Your First Visit
What Is Melanoma
Melanoma Treatment
Coping with Melanoma
Current Protocols
Current Therapy
Melanoma Video Q&A
Video Clinical Trials
Publications
Melanoma Donations
Melanoma Contact

© 2004 - 2008
All rights reserved.
Northern California
Melanoma Center

Disclaimer

 

 

 

 

 

 

 

 

Dr Spitler for the treatment of metastatic melanomaLynn E. Spitler, M.D.

Dr. Lynn E. Spitler received her M.D. from the University of Michigan Medical School and completed her Residency in Internal Medicine and Fellowship in Immunology. She then joined the faculty at the University of California Medical Center where with three other physicians she founded the UCSF Melanoma Clinic in 1969.

In 1978, she founded the Melanoma Clinic at Children's Hospital of San Francisco, the forerunner of the current Northern California Melanoma Center (NCMC).

Dr. Spitler's particular interest is in therapies aimed at preventing recurrence of melanoma in patients who have been rendered clinically tumor free by surgery or other therapeutic modalities but have high risk for recurrence. An example of such a patient would be someone who has had spread of the melanoma from a primary melanoma to regional lymph nodes. Standard therapy is to surgically excise the lymph nodes and some doctors recommend that this be followed by high-dose interferon. Interferon therapy is toxic and is not very effective. Dr. Spitler believes we need to find agents that are more effective and less toxic. Therefore, the Northern California Melanoma Center is conducting trials of agents which boost the immune response in an effort to help the patient's own immune system recognize tumor cells as foreign and reject them thus delaying or preventing recurrence of the melanoma.

Dr. Spitler says, "If you can treat a patient who already has had a melanoma and is at high risk for recurrence with an agent which will prevent or delay the recurrence, you have done a real service for the patient, because you have provided a period of good quality of life." There are a number of therapeutic options for patients in this category as discussed in "Surgical Adjuvant Treatment of Melanoma". They are available now and many patients are referred to the NCMC for information regarding these therapeutic options.



Dr. WeberDr. Robert Weber

Dr. Robert Weber is a Board Certified specialist in Internal Medicine and in Hematology and Oncology. He joined the consulting panel of physicians at the Northern California Melanoma Center in 2000 as Associate Director. He is particularly interested in clinical research in oncology.

Dr. Weber performs a physical examination of all new patients who come to the clinic and presents their history and physical to the physicians on the melanoma panel. After the consulting panel convenes, Dr. Weber, along with Dr. Spitler, meets with the patients and provides them with the treatment recommendations reached by the panel.

In addition to his work at NCMC, Dr. Weber has a private practice in oncology in San Francisco. He is a member of the teaching faculty of the St. Mary’s Hospital Residency Program and Chair of the Cancer Committee.



Dr. AllenDr. Robert E. Allen, Jr.

Dr. Robert E. Allen, Jr. is the oncologic surgeon for the Northern California Melanoma Center. He has been specializing in surgery for patients with melanoma for over 30 years.

Dr. Allen graduated from Meharry Medical College and completed residency training at Sparrow Hospital, the University of California, San Francisco, and Memorial Sloan-Kettering Hospital, New York. He is board certified by the American Board of Surgery and is a Clinical Professor of Surgery emeritus at the Mt. Zion Medical Center of the University of California San Francisco Medical Center.


 

 


Quest Assignments